This company is no longer active
Gemini Therapeutics Future Growth
How is Gemini Therapeutics forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Future Growth Score
0/6Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
20.9%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2024 | N/A | -14 | -12 | N/A | 1 |
| 12/31/2023 | N/A | -14 | -12 | N/A | 1 |
| 9/30/2022 | N/A | -43 | -43 | -43 | N/A |
| 6/30/2022 | N/A | -59 | -55 | -55 | N/A |
| 3/31/2022 | N/A | -68 | -61 | -61 | N/A |
| 12/31/2021 | N/A | -72 | -60 | -60 | N/A |
| 9/30/2021 | N/A | -68 | -56 | -56 | N/A |
| 6/30/2021 | N/A | -60 | -47 | -47 | N/A |
| 3/31/2021 | N/A | -50 | -38 | -38 | N/A |
| 12/31/2020 | N/A | -41 | -33 | -33 | N/A |
| 9/30/2020 | N/A | -36 | -35 | -35 | N/A |
| 6/30/2020 | N/A | -37 | -37 | -37 | N/A |
| 3/31/2020 | N/A | -41 | -39 | -39 | N/A |
| 12/31/2019 | N/A | -41 | -39 | -39 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GMTX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: GMTX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: GMTX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if GMTX's revenue is forecast to grow faster than the US market.
High Growth Revenue: GMTX is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if GMTX's Return on Equity is forecast to be high in 3 years time